Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Novel caspase-1 inhibitors designed at Vertex

Oct. 15, 1999

Anti-PECAM-1 antisense compounds for inflammation, cell hyperproliferation designed at Isis

Oct. 15, 1999

Celgene discovers new class of compounds inhibiting inflammatory cytokine production

Oct. 14, 1999

Apotex describes new inhibitors of cysteine proteases in recent patent literature

Oct. 8, 1999

New MMP inhibitors from Leo reportedly superior to structurally related compounds

Oct. 8, 1999

PLA2 inhibitors remain a focus of research at Genetics Institute

Oct. 6, 1999

rhPM-1 inhibits synovial cell proliferation in vitro, inflammatory cell infiltration in vivo

Oct. 5, 1999

British Biotech moves novel rheumatoid arthritis treatment into development

Oct. 4, 1999

Cytokine inhibitors from Ortho-McNeil and methods of treating rheumatoid arthritis, etc.

Oct. 4, 1999

American Cyanamid presents newest MMP inhibitors

Oct. 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...